SARS-CoV-2

Caolann Brady1,2, Tom Tipton3,4, Oliver Carnell5

  • 1Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. caolann.brady@well.ox.ac.uk.

NPJ vaccines
|April 14, 2025
PubMed
概括

对SARS-CoV-2尖端蛋白的抗体是保护的关键相关物,预测减少病毒载量和病理. 预先存在的免疫和特定的免疫细胞反应会影响抗体水平,影响疫苗的疗效.